BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34983270)

  • 21. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study.
    Sakamoto Y; Koga M; Yamagami H; Okuda S; Okada Y; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Hasegawa Y; Kario K; Arihiro S; Sato S; Kobayashi J; Tanaka E; Nagatsuka K; Minematsu K; Toyoda K;
    Stroke; 2013 Jul; 44(7):1846-51. PubMed ID: 23704107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort.
    Tanaka K; Koga M; Fukuda-Doi M; Qureshi AI; Yamamoto H; Miwa K; Ihara M; Toyoda K;
    Stroke; 2022 Jun; 53(6):1854-1862. PubMed ID: 35400202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of early pyrexia in acute intracerebral haemorrhage: The INTERACT2 study.
    Malavera A; You S; Zheng D; Delcourt C; Anderson CS;
    J Neurol Sci; 2021 Apr; 423():117364. PubMed ID: 33647734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive Care Unit Admission for Patients in the INTERACT2 ICH Blood Pressure Treatment Trial: Characteristics, Predictors, and Outcomes.
    Wartenberg KE; Wang X; Muñoz-Venturelli P; Rabinstein AA; Lavados PM; Anderson CS; Robinson T;
    Neurocrit Care; 2017 Jun; 26(3):371-378. PubMed ID: 28000127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage.
    Sato S; Delcourt C; Zhang S; Arima H; Heeley E; Zheng D; Al-Shahi Salman R; Stapf C; Tzourio C; Robinson T; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2016; 41(1-2):80-6. PubMed ID: 26671408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage.
    Toyoda K; Koga M; Yamamoto H; Foster L; Palesch YY; Wang Y; Sakai N; Hara T; Hsu CY; Itabashi R; Sato S; Fukuda-Doi M; Steiner T; Yoon BW; Hanley DF; Qureshi AI;
    Ann Neurol; 2019 Jan; 85(1):105-113. PubMed ID: 30421455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A practical prediction model for early hematoma expansion in spontaneous deep ganglionic intracerebral hemorrhage.
    Takeda R; Ogura T; Ooigawa H; Fushihara G; Yoshikawa S; Okada D; Araki R; Kurita H
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1028-31. PubMed ID: 23245855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review.
    Toyoda K; Yoshimura S; Fukuda-Doi M; Qureshi AI; Martin RH; Palesch YY; Ihara M; Suarez JI; Okada Y; Hsu CY; Itabashi R; Wang Y; Yamagami H; Steiner T; Sakai N; Yoon BW; Inoue M; Minematsu K; Yamamoto H; Koga M;
    Int J Stroke; 2022 Jun; 17(5):494-505. PubMed ID: 34542358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study).
    Koga M; Toyoda K; Yamagami H; Okuda S; Okada Y; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Hasegawa Y; Kario K; Osaki M; Miyagi T; Endo K; Nagatsuka K; Minematsu K;
    J Hypertens; 2012 Dec; 30(12):2357-64. PubMed ID: 22990355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial.
    Graffagnino C; Bergese S; Love J; Schneider D; Lazaridis C; LaPointe M; Lee K; Lynch G; Hu MY; Williams GC
    Cerebrovasc Dis; 2013; 36(3):173-80. PubMed ID: 24135526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.
    Morotti A; Shoamanesh A; Oliveira-Filho J; Schlunk F; Romero JM; Jessel M; Ayres A; Vashkevich A; Schwab K; Cassarly C; Martin RH; Greenberg SM; Qureshi AI; Rosand J; Goldstein JN;
    Neurocrit Care; 2020 Feb; 32(1):180-186. PubMed ID: 31218636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial.
    Manning L; Hirakawa Y; Arima H; Wang X; Chalmers J; Wang J; Lindley R; Heeley E; Delcourt C; Neal B; Lavados P; Davis SM; Tzourio C; Huang Y; Stapf C; Woodward M; Rothwell PM; Robinson TG; Anderson CS;
    Lancet Neurol; 2014 Apr; 13(4):364-73. PubMed ID: 24530176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studies.
    Guo R; Blacker DJ; Wang X; Arima H; Lavados PM; Lindley RI; Chalmers J; Anderson CS; Robinson T;
    Neurosurgery; 2017 Dec; 81(6):980-985. PubMed ID: 28605557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an INTEnsive blood pressure Reduction in Acute Cerebral hemorrhage Trial (INTERACT2): protocol and baseline characteristics of patients included in France].
    Delcourt C; Stapf C; Tzourio C; Héritier S; Anderson C
    Rev Neurol (Paris); 2012 Apr; 168(4):321-7. PubMed ID: 22129475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial.
    Yu S; Arima H; Heeley E; Delcourt C; Krause M; Peng B; Yang J; Wu G; Chen X; Chalmers J; Anderson CS;
    J Neurol Sci; 2016 Feb; 361():112-6. PubMed ID: 26810526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor utility of grading scales in acute intracerebral hemorrhage: results from the INTERACT2 trial.
    Heeley E; Anderson CS; Woodward M; Arima H; Robinson T; Stapf C; Parsons M; Lavados PM; Huang Y; Wang Y; Crozier S; Parry-Jones A; Wang J; Chalmers J;
    Int J Stroke; 2015 Oct; 10(7):1101-7. PubMed ID: 26044442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Unsolved Conundrum of Optimal Blood Pressure Target During Acute Haemorrhagic Stroke: A Comprehensive Analysis.
    Mulè G; Sorce A; Giambrone M; Fierro B; Cottone S; Cerasola G
    High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):119-126. PubMed ID: 30779025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medical therapy for intracranial hemorrhage: update blood pressure management for prevention and acute treatment].
    Koga M; Toyoda K
    Rinsho Shinkeigaku; 2012; 52(11):1110-2. PubMed ID: 23196532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.
    Morotti A; Brouwers HB; Romero JM; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
    JAMA Neurol; 2017 Aug; 74(8):950-960. PubMed ID: 28628707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Insights into Blood Pressure Control for Intracerebral Haemorrhage.
    Manning LS; Robinson TG
    Front Neurol Neurosci; 2015; 37():35-50. PubMed ID: 26588787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.